Dermal factors influencing measurement of skin autofluorescence

Diabetes Technology and Therapeutics

Volumn 13, Issue 2, 2011, Pages 165-170

  Noordzij, Margaretha J ^a   Lefrandt, Joop D ^a   Graaff, Reindert ^b   Smit, Andries J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALCOHOL; BODY CREAM; BODY LOTION; DAY CREAM; DERMATOLOGICAL AGENT; SELF BROWNING CREAM; SOAP; SUNSCREEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOFLUORESCENCE; BATH; CHEMICAL ANALYSIS; CLEANING; CONTROLLED STUDY; CUTANEOUS PARAMETERS; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN EXPERIMENT; HYDRATION; HYPEREMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN CARE; TISSUE LEVEL; VASOCONSTRICTION; VASODILATATION; WATER IMMERSION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; OINTMENTS; RENAL INSUFFICIENCY; SKIN; VASOCONSTRICTION; YOUNG ADULT;

EID: 79551609532     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0123     Document Type: Article

References (18)

1. 165-170 1. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995;46:223-234.
2. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, Gans RO, Bilo HJ: Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008;31:517-521
3. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ: Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007; 30:107-112
4. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ: Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.Diabetologia 2009;52:789-797.
5. Hartog JW, de Vries AP, Lutgers HL, Meerwaldt R, Huisman RM, van Son WJ, de Jong PE, Smit AJ: Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.AnnNYAcad Sci 2005;1043:299-307.
6. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ: Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005;16:3687-3693.
7. Basta G: Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008;196:9-21.
8. Goldin A, Beckman JA, Schmidt AM, Creager MA: Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006;114:597-605.
9. Baynes JW, Thorpe SR: Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 2000;28:1708-1716.
10. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, lderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ: Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330.
11. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ: Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006;29:2654-2659.
12. Mulder DJ, van Haelst PL, Gross S, de Leeuw K, Bijzet J, Graaff R, Gans RO, Zijlstra F, Smit AJ: Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 2008;197:217-223.
13. Koetsier M, Lutgers H, Smit AJ, Links TP, Vries RD, Gans RO, Rakhorst G, Graaff R: Skin autofluorescence for the risk assessment of chronic complications in diabetes: a broad excitation range is sufficient. Opt Express 2009;17:509-519.
14. Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, Smit AJ: Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006;8:523-535.
15. Stirban A, Nandrean S, Negrean M, Koschinsky T, Tschoepe D: Skin autofluorescence increases postprandially in human subjects. Diabetes Technol Ther 2008;10:200-205.
16. Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R: Reference values of skin autofluorescence. Diabetes Technol Ther 2010;12:399-403.
17. Braverman IM: The cutaneous microcirculation. J Investig Dermatol Symp Proc 2000;5:3-9.
18. Konig K: Multiphoton microscopy in life sciences. J Microsc 2000;200:83-104.